Xencor (XNCR) Cash & Equivalents (2013 - 2026)
Xencor (XNCR) reported Cash & Equivalents of $44.66 million for Q2 2026, up 0.5% from $44.44 million a year earlier and up 215.2% from the prior quarter.
Powered by 
Analysis
Xencor (XNCR) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Xencor posted Cash & Equivalents of $54.07 million, up 32.3% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -19.9% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $40.88 million in FY2024 (-24.0%), $53.79 million in FY2023 (-0.3%), $53.94 million in FY2022 (-62.4%) and $143.48 million in FY2021 (-12.3%).
- Five-year quarterly Cash & Equivalents spans a low of $14.17 million in Q1 2026 and a high of $143.48 million in Q4 2021.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with an average decline of 3.8%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2025 (growth of 44.4%); the low point was Q1 2026 (a decline of 64.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.17 million (Q1 2026), $54.07 million (Q4 2025) and $28.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Xencor | 1.85 Bn | 262.13 Mn | - | 44.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.66 Mn |
| Mar 31, 2026 | 14.17 Mn |
| Dec 31, 2025 | 54.07 Mn |
| Sep 30, 2025 | 28.29 Mn |
| Jun 30, 2025 | 44.44 Mn |
| Mar 31, 2025 | 39.68 Mn |
| Dec 31, 2024 | 40.88 Mn |
| Sep 30, 2024 | 29.03 Mn |
| Jun 30, 2024 | 30.77 Mn |
| Mar 31, 2024 | 31.03 Mn |
| Dec 31, 2023 | 53.79 Mn |
| Sep 30, 2023 | 52.73 Mn |
| Jun 30, 2023 | 34.71 Mn |
| Mar 31, 2023 | 72.39 Mn |
| Dec 31, 2022 | 53.94 Mn |
| Sep 30, 2022 | 52.65 Mn |
| Jun 30, 2022 | 49.41 Mn |
| Mar 31, 2022 | 78.27 Mn |
| Dec 31, 2021 | 143.48 Mn |
| Sep 30, 2021 | 41.20 Mn |
API Access
Xencor Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XNCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "XNCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XNCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();